Will Tough Restrictions Hinder Loblaw’s Success?

Competition Bureau imposes stiff rules on Loblaw’s merger with Shoppers.

| More on:
The Motley Fool

Since the first announcement that Loblaw (TSX: L) would be purchasing Shoppers Drug Mart (TSX: SC) for $12.4 billion, investors have been waiting for the Federal Competition Bureau to approve the deal. The FCB has given the green light for the merger, but has attached a couple of restrictions to ensure continued competitiveness in the market.

Relief to suppliers

The first stipulation imposed by the FCB has to do with how Loblaw can deal with current suppliers of Shoppers, and how it can leverage its new market share to set prices. These “behavioural restrictions,” which will be in effect for the next five years, are intended to prevent Loblaw from pushing up wholesale prices for its competitors.

Another restriction comes in the form of Loblaw being prohibited from “signing agreements that use sales volume at Shoppers as extra weight for its existing profit margin agreements.”

A major factor in the FCB imposing these new forms of restriction may stem from how Sobeys, a division of Empire Company Limited (TSX:EMP.A) has been battling its suppliers since the acquisition of Safeway.

The sell off

The other key piece of the FCB decision comes in the form of disinvestment, Loblaw has been ordered to sell off 14 Shoppers locations and four Loblaw stores. This is similar to the FCB ordering Sobeys to disinvest 23 locations as a condition of approving its Safeway merger. The majority of the locations ordered to be disinvested are located in smaller mostly rural communities spread over nine provinces.

Foolish bottom line

Now that the FCB has given its approval, Loblaw expects the deal to be completed by March 28, 2014. This news pushed Shoppers stock to a 52-week high of $61.88, and Loblaw saw a modest bump and closed up 1.7% at $47.01. Once completed Loblaw is predicting that it will be able to generate about $300 million in annual savings by 2017, and expects to achieve this without any store closures.

This merger places Loblaw in an interesting place in the market, first off it has acquired a massive foothold in the pharmacy and wellness sector. Also it has gained a substantial footprint in rural and suburban Canada, a place where it would not be cost-effective to build and operate a Superstore.

Fool contributor Cameron Conway does not own any shares in the companies mentioned.

More on Investing

Redwood forest shows growth potential with time
Dividend Stocks

3 Canadian Stocks Yielding 4%+ That Still Have Growth Potential

A 4%+ yield works best when it’s backed by real cash flow and a plan to grow, not just a…

Read more »

slow sloth in Costa Rica
Stocks for Beginners

4 Canadian Stocks That Look Strong Even in a Slow-Growth World

In slow growth, the best Canadian stocks usually have repeat customers, pricing power, and balance sheets that can handle higher…

Read more »

Man meditating in lotus position outdoor on patio
Dividend Stocks

This Canadian Dividend Stock Is Down 21% and Still a Forever Buy

Gildan Activewear stock is down 21%, but its HanesBrands acquisition, $250 million in synergies, and 20–25% EPS growth make it…

Read more »

Canadian dollars in a magnifying glass
Dividend Stocks

Undervalued Canadian Stocks to Buy Now

Here are some quality Canadian stocks trading at a discount that you can consider buying on dips.

Read more »

running robot changes direction
Dividend Stocks

4 TSX Stocks to Buy Now as Investors Rotate Back to Value

Value rotations reward companies with real cash flow, fair prices, and dividends you can collect while you wait.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, March 19

Cautious signals from the BoC and Fed triggered a sharp TSX selloff, with today’s tone expected to be shaped by…

Read more »

upside down girl playing on swing over the sea,
Dividend Stocks

A Dependable Dividend Stock to Buy With $20,000 Right Now

This dependable stock has the ability consistently pay and increase its yearly payouts regardless of market conditions.

Read more »

Concept of big data flow, analysis, and visualizing complex information for artificial intelligence
Tech Stocks

Down 12% Over the Past Year, Is it Time to Buy Kinaxis Stock?

Here's why Kinaxis (TSX:KXS) stock is starting to look like a screaming buy, no matter what the naysayers in the…

Read more »